You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 31 - 40 of 5400 results
  1. STTR Phase II: Low Temperature Cofired Multilayer Ceramic Power Transformers Incorporating Base Metallization Materials

    SBC: Solid State Ceramics, Inc.            Topic: EW

    The broader impact/commercial potential of this project is to a wide range of electronics in the areas of communications, Internet, portable electronics, and power electronics. Although magnetic based transformers have been the industry standard for over a century they have many negatives including miniaturization difficulties, electromagnetic interference issues, and issues with larger voltage st ...

    STTR Phase II 2016 National Science Foundation
  2. Discovery of alpha4beta2 Nicotinic Receptor Antagonists as Alcohol Abuse Medications

    SBC: ASSUAGE PHARMACEUTICALS, INC.            Topic: NIAAA

    PROJECT SUMMARY Alcohol addiction and disorders associated to excessive alcohol use are a serious public health problem in the United States and in other parts of the world Current pharmacotherapies for the treatment of these disorders show limited efficacy Preclinical and clinical findings point to nicotinic acetylcholine receptors nAChRs as an alternative promising target for the developmen ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Proteasome inhibitor re-sensitizing molecules for treatment of refractory multiple myeloma

    SBC: LEUKOGENE THERAPEUTICS INC            Topic: 102

    Project Summary Abstract Multiple Myeloma MM is the second most common form of blood cancer and remains an incurable and deadly disease Proteasome inhibitor PI therapy is a cornerstone in the treatment of MM but resistance to this class of agent is an emerging challenge in the clinic New therapeutic approaches that specifically target resistance are needed to maximize responses and ultimate ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  4. Maximizing cancer synthetic lethality using dual PI-3K/PARP inhibitors

    SBC: SignalRx Pharmaceuticals Inc.            Topic: NCI

    PARP inhibitors PARPi are particularly efficacious in tumors deficient in the BRCA tumor suppressor genes but of limited activity in BRCA competent tumors There is an unmet medical need to develop targeted therapeutic agents which will augment PARPi activity for BRCA wild type cancers and to increase chemo radiosensitivity in these malignancies BRCA proteins are essential components ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Promoting Self-Care and Coping for Alzheimer's Caregivers

    SBC: ISA ASSOCIATES INC            Topic: NIA

    Project Summary Abstract An estimated million adults in the United States currently provide informal care to relatives and friends with Alzheimer s disease The economic contribution of informal caregivers service is estimated in the billions and is the cornerstone of care for the million people with the disease While informal caregivers undoubtedly perform an important role the respon ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  6. A Humanized Swine Model for Alzheimer's Disease

    SBC: Recombinetics, Inc.            Topic: NIA

    PROJECT SUMMARY Alzheimer s disease AD affects million people worldwide costing $ billion yearly One in nine Americans over the age of have AD the th leading cause of death in the US Annually $ billion is spent to care for the million Americans with AD AD is the only cause of death in the top that cannot be prevented cured or slowed and without the development of tre ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Development of immuno-PET agents for the selective imaging of CD8 T cells

    SBC: Agenus Inc.            Topic: 102

    Project summary Therapeutic strategies that seek to stimulate adaptive immunity for the treatment of cancer have recently shown convincing clinical efficacy Immune checkpoint inhibitors CPIs for example reactivate a patient s own T cells to eliminate tumors by blocking interactions that cause tumor infiltrating lymphocytes TILs to become exhausted CPIs have demonstrated remarkable success ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  8. EEG Patch

    SBC: EPITEL, INC.            Topic: 106

    ABSTRACT The EEG PatchTM is a single channel electrode wearable patch like device designed for long term EEG recording in people with epilepsy to be used in their everyday environment To maximize the treatment of epilepsy it is critical to capture important day to day changes in EEG activity for long periods including the occurrence and duration of epileptiform events such as spike wave d ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Establishing the Functional Viability and Dose Response of Duck Duck Punch A Stroke Rehabilitation Computer Game

    SBC: Recovr, Inc.            Topic: 108

    Establishing the functional viability and dose response of Duck Duck Punch A Stroke Rehabilitation Computer Game ABSTRACT Only of stroke survivors experience full recovery of arm hand movement Long term arm movement impairment restricts independence with self care and vocational activities increases caregiver burden and reduces quality of life Strong evidence is emerging that traditional ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  10. SBIR Phase II: Development of Advanced Composite Materials for Athletic Equipment

    SBC: Mallinda Inc.            Topic: MI

    This Small Business Innovation Research (SBIR) Phase II project is for the development of scaled processes for the industrial manufacture of end-user moldable advanced composite materials for use in protective athletic equipment. Currently, protective athletic equipment and accessories must be produced using industrial manufacturing techniques that have high tooling costs. As a result, manufacture ...

    SBIR Phase II 2016 National Science Foundation
US Flag An Official Website of the United States Government